These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 363195)

  • 1. The logistics of clinical trials.
    Bonadonna G; Valagussa P
    Biomedicine; 1978 Sep; 28 Spec No():43-8. PubMed ID: 363195
    [No Abstract]   [Full Text] [Related]  

  • 2. Delaware/Christiana Care Community Clinical Oncology Program (CCOP): a National Cancer Institute clinical trials program.
    Price K
    Del Med J; 2007 Jun; 79(6):247-51. PubMed ID: 17621871
    [No Abstract]   [Full Text] [Related]  

  • 3. Size of phase III cancer clinical trials.
    Simon R
    Cancer Treat Rep; 1985 Oct; 69(10):1087-93. PubMed ID: 4042088
    [No Abstract]   [Full Text] [Related]  

  • 4. How to evaluate improvements in cancer treatment: the debate continues.
    Jones SE
    Biomedicine; 1978 Sep; 28 Spec No():55-7. PubMed ID: 363198
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer clinical trials in the USA: patient eligibility, generalizability of results and technology transfer.
    Begg CB
    Bull Cancer; 1987; 74(2):197-203. PubMed ID: 3607303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical and conceptual limitations of best conceived randomized trials.
    Israel L
    Biomedicine; 1978 Sep; 28 Spec No():36-9. PubMed ID: 363192
    [No Abstract]   [Full Text] [Related]  

  • 7. The ethical approach to randomization in oncology.
    Arpaillange P; Dion S
    Drugs Exp Clin Res; 1986; 12(1-3):99-103. PubMed ID: 3732058
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial methodology.
    Peto R
    Biomedicine; 1978 Sep; 28 Spec No():24-36. PubMed ID: 363191
    [No Abstract]   [Full Text] [Related]  

  • 9. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards ecumenism for comparative trials.
    Mathé G
    Biomedicine; 1978 Sep; 28 Spec No():2-6. PubMed ID: 363190
    [No Abstract]   [Full Text] [Related]  

  • 11. [Randomization: apropos of controlled prospective studies in chemotherapy].
    Charron C
    Soins; 1986 Aug; (483-484):18-20. PubMed ID: 3640551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methodological forms of clinical studies in surgery: indication and evaluation].
    Lorenz W; Ohmann C
    Chirurg; 1983 Apr; 54(4):189-95. PubMed ID: 6851741
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical advances in pediatric hematology & oncology: cooperative group research.
    Reaman GH
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):133-5. PubMed ID: 16166982
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer treatment: clinical trials vs. local teams.
    Ismach J
    Med World News; 1981 Jan; 22(1):79-80, 85-6, 92 passim. PubMed ID: 10259354
    [No Abstract]   [Full Text] [Related]  

  • 15. The Kos statement on randomization. First International Meeting, Kos 1986; Second International Meeting, Paris 1987.
    Biomed Pharmacother; 1988; 42(3):167. PubMed ID: 3179401
    [No Abstract]   [Full Text] [Related]  

  • 16. [Organization of an oncological service and oncological research in Italy].
    Kiselev AK
    Vopr Onkol; 1978; 24(5):46-51. PubMed ID: 664535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ethics of randomization].
    Arpaillange P; Dion S
    Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].
    Byar D; Chastang C
    Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy and alternate randomized designs in cancer clinical trials.
    Zelen M
    Cancer Treat Rep; 1982 May; 66(5):1095-100. PubMed ID: 7083213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.